American Heart Association Clarifies Role of Coronary Artery Calcium Testing in Preventive Care

By The Building Texas Show•
The American Heart Association emphasizes that CAC testing is a selective decision-making tool, not a universal screening test, for individuals at borderline or intermediate cardiovascular risk.

Found this article helpful?

Share it with your network and spread the knowledge!

American Heart Association Clarifies Role of Coronary Artery Calcium Testing in Preventive Care

The American Heart Association is urging consumers and clinicians to view coronary artery calcium (CAC) testing as a targeted decision aid rather than a routine screening tool for heart disease. According to a release distributed via NEWMEDIAWIRE, the CAC test is a quick, noninvasive CT scan that detects calcium deposits in the coronary arteries, which can be an early sign of plaque buildup, or atherosclerosis. The resulting calcium score offers individuals and their healthcare professionals another piece of information about future risk of cardiovascular disease or events such as heart attack or stroke. The scan takes about 10 to 15 minutes, does not require injected contrast dye and uses a low dose of radiation.

However, the Association stresses that CAC testing is not necessary for everyone. The American Heart Association/American College of Cardiology dyslipidemia guideline supports selective use of CAC scoring, particularly when a person's cardiovascular risk falls in a middle range and there is uncertainty about whether to begin or intensify cholesterol-lowering treatment. The 2026 guideline for medical professionals encourages the use of the American Heart Association’s PREVENT™ equations as the starting point for estimating cardiovascular risk and identifies CAC as a tool that can help refine treatment decisions when the answer remains unclear.

“The American Heart Association does not recommend broad based use of the CAC test for screening. The Association recommends it as a decision aid for people at borderline or intermediate risk for atherosclerotic cardiovascular disease or heart and blood-vessel disease caused by the buildup of cholesterol-containing plaque in the arteries – but only when the decision about whether to use drug therapy to lower risk is uncertain. It is a tiebreaker test,” said Manesh R. Patel, M.D., FAHA, volunteer president of the American Heart Association and chief of the division of cardiology at Duke University School of Medicine.

Recent research and media coverage have highlighted that important distinction: CAC provides the greatest value when the result can change a treatment decision. New studies have found that modern risk estimation with the Association’s PREVENT equations can identify coronary artery disease risk effectively for many people, while adding CAC information can be particularly useful for people in borderline (3% to less than 5%) and intermediate (5% to less than 10%) risk groups. The Association’s guidelines recommend using calcium findings to help inform decisions on the use of statins for men age 40 and older and women age 45 and older with borderline or intermediate 10-year risk of heart attack or stroke.

For consumers, the Association outlines four key points about CAC. First, the first step is a conversation, not necessarily a scan. People should talk with their healthcare professional about their overall cardiovascular risk and whether knowing their CAC score would actually change what they do next. It generally isn't useful when cardiovascular risk is already very low or when the appropriate treatment is already clear, such as for those with diabetes or very high cholesterol. Second, the scan looks for evidence of plaque already in the coronary arteries. It is typically not covered by health insurance and can cost the patient $100 to $400. Third, it should be viewed as a potential decision-making tool, not an annual screening test. The Association recommends that the “first prescription” for prevention should be lifestyle modification, including avoiding smoking and tobacco use and emphasizing a healthy diet, exercise and sleep as defined by the Association’s Life’s Essential 8™. Fourth, a score of zero is reassuring, but it isn't a lifetime “all clear.” A CAC score of zero doesn’t rule out noncalcified plaque, and other factors such as diabetes, smoking, very high cholesterol and a strong family history of premature heart disease still matter.

For those seeking more information, the Association offers coronary artery calcium testing (CAC test) from the American Heart Association, which explains who may benefit, who may not need the test, what happens during the scan and what to discuss with a healthcare professional. Individuals can also use the Life's Essential 8™ My Life Check Calculator to learn their own heart health score at home and get personalized tips to set health goals and start a conversation with their healthcare team. Additional resources include the Association’s national Catalyzing CAC Testing to Transform Heart Health initiative and the About the PREVENT™ Equations page for background and frequently asked questions.

This news matters for Texas businesses and residents because cardiovascular disease remains a leading cause of death and disability, and unnecessary testing can drive up healthcare costs. By clarifying that CAC testing is a tiebreaker for select patients, the American Heart Association aims to reduce overuse while ensuring those who need extra information to make treatment decisions can access it. For employers, understanding these guidelines can inform wellness programs and benefits design, potentially improving workforce health and productivity. The emphasis on lifestyle modification as the first prescription also underscores the role of preventive care in controlling long-term healthcare spending.